Literature DB >> 17855526

Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo.

Nelson C Di Paolo1, Oleksandr Kalyuzhniy, Dmitry M Shayakhmetov.   

Abstract

The molecular mechanisms governing the infectivity of adenovirus (Ad) toward specific cell and tissue types in vivo remain poorly understood. The direct Ad binding to hepatic heparan sulfate proteoglycans via the KKTK motif within the fiber shaft domain was suggested to be the major mechanism of Ad liver cell infection in vivo. Here, we describe the generation and in vitro and in vivo infectivity studies of Ad5-based vectors possessing long Ad31- or Ad41-derived fiber shaft domains, which lack the KKTK motif. We found that all the critical early steps of Ad infection, including attachment to the cellular receptor, internalization, and virus genome transfer into the nucleus, occurred with similar levels of efficiency for fiber shaft-chimeric vectors and unmodified Ad5. Upon intravenous delivery into mice, fiber shaft-chimeric vectors accumulated in liver tissue, transduced liver cells, and induced the production of proinflammatory cytokines (tumor necrosis factor alpha and interleukin-6) and the chemokine monocyte chemoattractant protein 1 at levels indistinguishable from those observed for Ad5. Thus, our data provide evidence that the Ad5 fiber shaft amino acid sequence does not play any substantial role in determining adenovirus infectivity toward hepatic cells in vivo. The data obtained contribute to improving our understanding of the molecular mechanisms determining Ad infectivity and biodistribution in vivo and may aid in designing novel Ad-based vectors for gene therapy applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855526      PMCID: PMC2168974          DOI: 10.1128/JVI.01584-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.

Authors:  R Alemany; D T Curiel
Journal:  Gene Ther       Date:  2001-09       Impact factor: 5.250

Review 3.  Endocytosis of adenovirus and adenovirus capsid proteins.

Authors:  Lali K Medina-Kauwe
Journal:  Adv Drug Deliv Rev       Date:  2003-11-14       Impact factor: 15.470

4.  Receptors mediating adenovirus attachment and internalization.

Authors:  J M Bergelson
Journal:  Biochem Pharmacol       Date:  1999-05-01       Impact factor: 5.858

5.  Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae.

Authors:  P W Roelvink; G Mi Lee; D A Einfeld; I Kovesdi; T J Wickham
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

6.  CD46 is a cellular receptor for group B adenoviruses.

Authors:  Anuj Gaggar; Dmitry M Shayakhmetov; André Lieber
Journal:  Nat Med       Date:  2003-10-19       Impact factor: 53.440

7.  Receptor interactions involved in adenoviral-mediated gene delivery after systemic administration in non-human primates.

Authors:  Theodore A G Smith; Neeraja Idamakanti; Jennifer Marshall-Neff; Michele L Rollence; Patrick Wright; Michele Kaloss; Laura King; Christine Mech; Lisa Dinges; William O Iverson; Alfred D Sherer; Judit E Markovits; Russette M Lyons; Michael Kaleko; Susan C Stevenson
Journal:  Hum Gene Ther       Date:  2003-11-20       Impact factor: 5.695

8.  Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates.

Authors:  Nicola Brunetti-Pierri; Donna J Palmer; Arthur L Beaudet; K Dee Carey; Milton Finegold; Philip Ng
Journal:  Hum Gene Ther       Date:  2004-01       Impact factor: 5.695

9.  Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

Authors:  M C Dechecchi; P Melotti; A Bonizzato; M Santacatterina; M Chilosi; G Cabrini
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions.

Authors:  M C Dechecchi; A Tamanini; A Bonizzato; G Cabrini
Journal:  Virology       Date:  2000-03-15       Impact factor: 3.616

View more
  18 in total

1.  With a little help from my f(X)riends!: the basis of Ad5-mediated transduction of the liver revealed.

Authors:  Pedro R Lowenstein
Journal:  Mol Ther       Date:  2008-06       Impact factor: 11.454

2.  Structure and N-acetylglucosamine binding of the distal domain of mouse adenovirus 2 fibre.

Authors:  Abhimanyu K Singh; Thanh H Nguyen; Márton Z Vidovszky; Balázs Harrach; Mária Benkő; Alan Kirwan; Lokesh Joshi; Michelle Kilcoyne; M Álvaro Berbis; F Javier Cañada; Jesús Jiménez-Barbero; Margarita Menéndez; Sarah S Wilson; Beth A Bromme; Jason G Smith; Mark J van Raaij
Journal:  J Gen Virol       Date:  2018-10-02       Impact factor: 3.891

Review 3.  The role of liver sinusoidal cells in hepatocyte-directed gene transfer.

Authors:  Frank Jacobs; Eddie Wisse; Bart De Geest
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

4.  Intermediate heparan sulfate binding during HPV-16 infection in HaCaTs.

Authors:  Annandita Kumar; Taylor Jacob; Cynthia Y Abban; Patricio I Meneses
Journal:  Am J Ther       Date:  2014 Sep-Oct       Impact factor: 2.688

5.  Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo.

Authors:  O Kalyuzhniy; N C Di Paolo; M Silvestry; S E Hofherr; M A Barry; P L Stewart; D M Shayakhmetov
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-07       Impact factor: 11.205

6.  A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.

Authors:  M K Magnusson; R Kraaij; R M Leadley; C M A De Ridder; W M van Weerden; K A J Van Schie; M Van der Kroeg; R C Hoeben; N J Maitland; L Lindholm
Journal:  Hum Gene Ther       Date:  2011-10-12       Impact factor: 5.695

7.  Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.

Authors:  Stéphanie Corjon; Gaëlle Gonzalez; Petra Henning; Alexei Grichine; Leif Lindholm; Pierre Boulanger; Pascal Fender; Saw-See Hong
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

8.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

Review 9.  Adenovirus receptors and their implications in gene delivery.

Authors:  Anurag Sharma; Xiaoxin Li; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2009-02-26       Impact factor: 3.303

10.  Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.

Authors:  Anniina Koski; Eerika Karli; Anja Kipar; Sophie Escutenaire; Anna Kanerva; Akseli Hemminki
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.